Further comparative trial of triethylene thiophosphoramide and mechlorethamine in patients with Melanoma and Hodgkin's disease
- 1 January 1964
- journal article
- Published by Elsevier in Journal of Chronic Diseases
- Vol. 17 (1) , 19-30
- https://doi.org/10.1016/0021-9681(64)90036-0
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramideJournal of Chronic Diseases, 1960
- USEFULNESS OF DUNNING LEUKEMIA IRC741 FOR QUANTITATIVE PHARMACOLOGICAL STUDIES OF CANCER CHEMOTHERAPEUTIC AGENTS*Annals of the New York Academy of Sciences, 1958
- Therapy of Choriocarcinoma and Related Trophoblastic Tumors with Folic Acid and Purine AntagonistsNew England Journal of Medicine, 1958
- The Treatment of Advanced Malignant MelanomaAnnals of Surgery, 1958
- TRIETHYLENEPHOSPHORAMIDE IN THE TREATMENT OF DISSEMINATED MELANOMAJAMA, 1958
- Biological effects of the phosphoramides in patients with advanced cancerCancer, 1957
- Therapy of the malignant lymphomas: I. A study of 116 casesThe American Journal of Medicine, 1956
- Clinical Trials of p-(Di-2-chloroethylamine)-phenylbutyric Acid (CB 1348) in Malignant LymphomaBMJ, 1955
- MYLERAN IN CHRONIC MYELOID LEUKÆMIAThe Lancet, 1955
- Clinical studies of triethylenethiophosphoramide in the treatment of inoperable cancerCancer, 1955